Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-820836 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2014
At a glance
- Drugs Liafensine (Primary)
- Indications Depressive disorders
- Focus Adverse reactions
- 04 Sep 2009 Actual patient number (68) added, trial location (Canada) added as reported by ClinicalTrials.gov.
- 26 Aug 2009 New trial record